Tumblelog by Soup.io
Newer posts are loading.
You are at the newest post.
Click here to check if anything new just came in.

Allegheny General Hospital Introduces New Treatment For Relapsing Multiple Sclerosis - Yahoo Finance

Lemtrada is only available in the U.S. through certified prescribers, healthcare facilities and specialty pharmacies and to patients who are enrolled in a Lemtrada risk evaluation and mitigation program. The program is designed to educate healthcare providers and patients on risks associated with Lemtrada, including serious autoimmune conditions. Monthly monitoring and blood tests are provided to patients to support the detection of these risks for 48 months after the last infusion. The clinical development program for Lemtrada involved nearly 1,500 patients with more than 6,400 patient-years of safety follow up.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/allegheny-general-hospital-introduces-treatment-100352826.html

Oral Pain Medications Overtake Injectable Therapies as Preferred Treatment for Multiple Sclerosis - Yahoo Finance

There is no hard proof; that would require extensive and expensive double-blind trials with many participants. But for Kristen, whose symptoms went from daily to non-existent, its proof enough. I would recommend Cynthia for any physical ailment youre trying to move past, said Kristen. Especially if youve been multiple sclerosis pain management told you have something chronic and incurable.
For the original version including any supplementary images or video, visit http://www.prweb.com/releases/hypnosisfor/multiplesclerosis/prweb12698073.htm

Can Hypnosis Help Relieve the Symptoms of Multiple Sclerosis?

Kristen has been symptom free since starting hypnosis (WHNT) Hundreds showed up Saturday, May 2 to walk to raise awareness about multiple sclerosis. Statistics show more than 400,000 people in the United States are diagnosed with the disease. During the Walk MS Huntsville event, people had the choice of walking one, two or three miles to raise money for the National Multiple Sclerosis Society . Public speaker Heath Campbell was diagnosed with MS in 1998 and multiple sclerosis jewelry says raising awareness helps each person affected. In this story Coming out here and helping, youre raising funds and awareness to help people with MS to get medication and stay on the medication that works for them, Campbell said. Each year, nearly 333,000 people across the United States walk in support of those affected by MS. 34.755701 -86.697614
For the original version including any supplementary images or video, visit http://whnt.com/2015/05/05/hundreds-participate-in-huntsvilles-walk-for-multiple-sclerosis/

Hundreds participate in Huntsville?s walk for Multiple Sclerosis | WHNT.com

For complimentary access to more information on this research, please visit: http://bit.ly/1QmTPPG . "Physicians prefer Avonex, Betaferon, Copaxone, Rebif or ABCRs as first line therapy because of the 10 years of clinical data establishing their efficacy and safety," saidFrost & Sullivan Healthcare Industry Analyst Aish Vivekanandan. "As is evident, clinical data substantiating the benefits of drugs will prove to be the driving factor in enabling rapid approvals from regulatory agencies." Relapsing-remitting multiple sclerosis (RRMS) is the most common form of MS particularly in the U.S. and Europe, and garners immense attention from drug manufacturers. Although, therapeutic drug development in the primary progressive multiple sclerosis (PPMS) segment leaves http://msrelief.info/exercise-and-multiple-sclerosis/ a lot to be desired. Drug manufacturers are now investing in R&D to achieve a greater understanding of PPMS disease pathology and reach this untapped market. Clinical studies researching the treatment of progressive MS and investigating the effects of vitamin D in relapsing MS are also underway.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/oral-pain-medications-overtake-injectable-113000908.html

Don't be the product, buy the product!